https://www.fda.gov/science-research/licensing-and-collaboration-opportunities/anthrax-lethal-toxin-inhibits-proliferation-human-cd4-t-cells-response-t-cell-receptor-stimulation
FDA researchers have developed a method using a human tumor CD4 T cell line to screen and determine the efficacy of anti-anthrax therapeutics.
anthrax lethal toxinproliferationhumancells